Edition:
United Kingdom

Caladrius Biosciences Q2 Loss Per Share $0.42 From Continuing Operations


Thursday, 9 Aug 2018 

Caladrius Biosciences Inc ::CALADRIUS BIOSCIENCES REPORTS 2018 SECOND QUARTER AND FIRST SIX MONTHS FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.42 FROM CONTINUING OPERATIONS.AS OF JUNE 30, 2018, CO HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $50.3 MILLION. 

Company Quote

3.0
-0.02 -0.66%
3:45pm BST